Cover Image
市場調查報告書

歐洲的胰島素注射器市場

European Market Report for Insulin Syringes 2016 - MedCore

出版商 iData Research Inc. 商品編碼 370972
出版日期 內容資訊 英文 61 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
歐洲的胰島素注射器市場 European Market Report for Insulin Syringes 2016 - MedCore
出版日期: 2016年09月01日 內容資訊: 英文 61 Pages
簡介

本報告提供歐洲的胰島素注射器市場相關調查分析,提供您市場概要,市場分析與預測,推動因素·阻礙因素,競爭分析等系統性資訊。

第1章 調查手法

第2章 疾病概要

  • 簡介
    • 糖尿病的種類
    • 糖尿病的併發症
    • 第一型·第二型糖尿病相關的危險因素
    • 徵兆與症狀
    • 糖尿病監測
    • 治療
    • 藥物遞輸系統

第3章 國家概況

  • 簡介
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 荷比盧三國
  • 北歐各國
  • 奧地利
  • 瑞士
  • 葡萄牙

第4章 胰島素注射器市場

  • 簡介
  • 市場分析與預測
  • 推動因素·阻礙因素
    • 推動市場要素
    • 市場阻礙因素
  • 競爭市場佔有率分析

簡稱

目錄
Product Code: iDATA_EUDD16_MC_IS

The insulin syringe market is a fast declining segment. Although the product was once a popular method of injecting insulin, patients have transitioned towards new technologies such as insulin pens and pumps, thereby cannibalizing the insulin syringe segment. Safety insulin syringes are now mainly used in professional healthcare settings, such as hospitals, whereas conventional syringes are no longer used as frequently. Syringe use is still relatively high in Italy due to historical trends, but it is expected that patients will continue to switch to insulin pens and pumps for convenience.

Insulin is a protein and when administered orally, it degrades in the stomach and the intestines. When administered subcutaneously, it is better absorbed and has more of an effect on blood sugar levels. Many alternative technologies have entered the insulin delivery device market, such as insulin pumps and insulin pens, resulting in a fast decline in insulin syringe use across Europe.

Insulin syringes are moving from being hypodermic to those with finer points. Syringes are used with 10 mL insulin vials and come in 0.3 mL, 0.5 mL and 1 mL calibrations. In addition, thinner and shorter syringes are becoming more popular in the market, as they cause less discomfort when giving an injection. Needle thickness is indicated by gauge number; the higher the gauge number, the thinner the needle.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

EUROPEAN MARKET FOR DIABETES MONITORING, TREATMENT AND DRUG DELIVERY

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

MARKETS INCLUDED

KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

  • 1.1 RESEARCH SCOPE
  • 1.2 IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

  • 2.1 INTRODUCTION
    • 2.1.1 Types of Diabetes
    • 2.1.2 Diabetes Complications
    • 2.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes
    • 2.1.4 Signs and Symptoms
    • 2.1.5 Diabetes Monitoring
    • 2.1.6 Treatment
    • 2.1.7 Drug Delivery Systems

COUNTRY PROFILES

  • 3.1 INTRODUCTION
    • 3.1.1.1 Population
    • 3.1.1.2 GDP Per Capita
    • 3.1.1.3 Units
  • 3.2 GERMANY
  • 3.3 FRANCE
  • 3.4 UNITED KINGDOM
  • 3.5 ITALY
  • 3.6 SPAIN
  • 3.7 BENELUX
  • 3.8 SCANDINAVIA
  • 3.9 AUSTRIA
  • 3.10 SWITZERLAND
  • 3.11 PORTUGAL

INSULIN SYRINGE MARKET

  • 4.1 INTRODUCTION
  • 4.2 MARKET ANALYSIS AND FORECAST
  • 4.3 DRIVERS AND LIMITERS
    • 4.3.1 Market Drivers
    • 4.3.2 Market Limiters
  • 4.4 COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS

Back to Top